Pelican Acquisition Corporation (PELIU) 股票分析
金融服务Pelican Acquisition Corporation
$9.90
+$0.45 (+4.76%)
最后更新: 2026年3月25日
价格走势
暂无价格数据
分析
公司概述
Pelican Acquisition Corporation operates primarily within the financial services sector, specifically classified under the industry of shell companies, which indicates its current focus is on facilitating a merger, share exchange, asset acquisition, share purchase, reorganization, or a similar business combination with one or more entities in the technology industry rather than conducting significant ongoing operations. The company's market capitalization and annual revenue figures are listed as N/A in available data, reflecting the typical characteristics of a special purpose acquisition company (SPAC) that has not yet completed a de-SPAC transaction or generated substantial operating revenue. Additionally, the employee count is recorded as N/A, suggesting that the organization may be utilizing a lean administrative structure or that personnel numbers are not publicly disclosed in standard financial filings. The absence of specific market cap and revenue data implies that the company exists in a transitional phase where its valuation is not yet driven by operational cash flows but rather by the potential value of the upcoming business combination with a technology target.
财务健康
The reported net income for the trailing twelve months stands at $1.25M, while revenue and EBITDA are listed as N/A, creating a distinct gap between revenue and net income that reveals a cost structure heavily reliant on non-operating income or sponsor support rather than core business operations. Free cash flow is reported at $-491,049, indicating a cash outflow that suggests the company is consuming cash reserves to fund its search for a target or ongoing administrative expenses, thereby limiting immediate financial flexibility for external expansion. All three key margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which indicates that the company has not yet generated significant revenue from its primary business activities or that its financial reporting reflects a pre-operational status where traditional margin analysis does not apply. The company holds $77 in cash against $199,940 in debt, resulting in a negative net cash position that highlights a leveraged balance sheet dependent on future capital raises or asset acquisitions to manage obligations. The debt-to-equity ratio is listed as N/A, but the disparity between cash and debt underscores a conservative liquidity posture that is currently strained by the debt load relative to available liquid assets. Furthermore, the current ratio is 0.28, a figure that critically indicates insufficient short-term assets to cover short-term liabilities, signaling potential liquidity challenges if the company cannot secure a deal quickly. Return on Equity and Return on Assets are both N/A or negative, with ROA specifically at -1.5%, revealing that management has not yet deployed capital to generate positive returns on the equity base or total assets held.
估值评估
Trailing P/E, forward P/E, and price-to-sales ratio are all listed as N/A, while EV/EBITDA is also N/A, meaning that traditional earnings-based valuation multiples cannot be applied to determine a fair value or expected earnings trajectory for this entity at this stage. The price-to-book ratio is -291.18, a negative figure that indicates the market capitalization is mathematically inconsistent with the book value in a conventional sense, often seen in SPACs where the trust value per share is distinct from the reported book value of the enterprise. Since revenue and earnings are not available, alternative valuation metrics like price-to-sales and EV/EBITDA provide no actionable insight, suggesting that valuation is currently driven by market sentiment regarding the quality of the prospective technology target rather than current financial performance. The stock has traded with a 52-week high of $13.52 and a 52-week low of $9.45, and without a specific current price in the provided facts, the exact trading position relative to this range cannot be calculated, though the wide spread suggests significant price volatility typical of shell companies awaiting a merger. Beta is listed as N/A, which prevents a direct comparison of price volatility relative to the broader market, but the historical trading range of nearly $4.07 per share indicates that the stock is highly sensitive to SPAC-specific market dynamics rather than general market beta movements.
Growth & Income
Revenue growth and earnings growth rates are both listed as N/A, which precludes any analysis of whether earnings are growing faster or slower than revenue, as the company has not yet established a recurring revenue stream or earnings history. Since the company does not pay dividends, the dividend yield and payout ratio are N/A, indicating that the company reinvests any available earnings or proceeds from its trust into the search for a business combination rather than distributing income to shareholders. The overall growth and income profile is characterized by a lack of historical financial growth metrics and a reliance on a future business combination event to generate both revenue and potential dividend-paying capabilities. This structural absence of growth data and income distribution confirms that the investment thesis rests entirely on the successful execution of a merger with a technology industry entity rather than on organic growth or current shareholder yields.
同行比较
Pelican Acquisition Corporation (PELIU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Pelican Acquisition Corporation | PELIU | N/A | N/A |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。Pelican Acquisition Corporation的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于Pelican Acquisition Corporation
Pelican Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in technology industry. Pelican Acquisition Corporation was incorporated in 2024 and is based in New York, New York.
公司简介以英文显示。
访问官网 →